Finding drug targets in microbial genomes

Drug Discovery Today

Volumn 6, Issue 17, 2001, Pages 887-892

  Read, Timothy D ^a   Gill, Steven R ^a   Tettelin, Hervé ^a   Dougherty, Brian A ^b  

^a J CRAIG VENTER INSTITUTE   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CIPROFLOXACIN; GENE PRODUCT; NEW DRUG; NOVOBIOCIN;

BACTERIAL GENE; BACTERIAL VIRULENCE; DNA MICROARRAY; DNA SEQUENCE; DRUG DESIGN; DRUG TARGETING; GENE FUNCTION; GENOME; INFECTION; INTERNET; NONHUMAN; PROTEIN TARGETING; REVIEW;

EID: 0035450611     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01914-6     Document Type: Review

References (52)

1. Changing patterns of infectious disease
2. New antibiotic discovery, novel screens, novel targets and impact of microbial genomics
3. Applied genomics: integration of the technology within pharmaceutical research and development
4. Bacterial targets and antibiotics: genome-based drug discovery
5. Harnessing the power of the genome in the search for new antibiotics
6. Status of genome projects for nonpathogenic bacteria and archaea
7. Microbial gene identification using interpolated Markov models
8. How to interpret an anonymous bacterial genome: machine learning approach to gene identification
9. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
10. Flexible sequence similarity searching with the FASTA3 program package
11. Pfam3.1: 1313 multiple alignments and profile HMMs match the majority of proteins
12. TIGRFAMs: a protein family resource for the functional identification of proteins
13. Iterated profile searches with PSI-BLAST - a tool for discovery in protein databases
14. A genomic perspective on protein families
15. Structure-based evaluation of sequence comparison and fold recognition alignment accuracy
16. Comparative genomes of Chlamydia pneumoniae and C. trachomatis.
17. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39
18. Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA
19. Concordance analysis of microbial genomes
20. Searching for drug targets in microbial genomes
21. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
22. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
23. TopPred II: an improved software for membrane protein structure predictions
24. A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
25. Expert system for predicting protein localization sites in Gram-negative bacteria
26. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection
27. Bacterial virulence as a target for antimicrobial chemotherapy
28. Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system
29. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution
30. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7
31. Microbial genome sequencing 2000: new insights into physiology, evolution and expression analysis
32. Global transposon mutagenesis and a minimal Mycoplasma genome
33. European Functional Analysis Network (EUROFAN) and the functional analysis of the Saccharomyces cerevisiae genome
34. In vivo genetic analysis of bacterial virulence
35. Integrated pathway-genome databases and their role in drug discovery
36. Functional analysis of gapped microbial genomes: amino acid metabolism of Thiobacillus ferrooxidans
37. Discovering high-affinity ligands for proteins: SAR by NMR
38. Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries
39. Virtual screening: an effective tool for lead structure discovery?
40. Exploring the new world of the genome with DNA microarrays
41. Gene expression analysis of the Streptococcus pneumoniae competence regulons by use of DNA microarrays
42. Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled by an autoinduced peptide
43. Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis
44. Comparative genomics of BCG vaccines by whole-genome DNA microarray
45. Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae
46. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains
47. DNA microarrays in drug discovery and development
48. The genome sequence of Rickettsia prowazekii and the origin of mitochondria
49. The complete genome sequence of Escherichia coli K-12
50. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis
51. Rickettsiae and Chlamydiae: evidence of horizontal gene transfer and gene exchange